Latest Ingelheim am Rhein Stories
DiabetesSisters has received joint funding from Boehringer-Ingelheim and Eli Lilly in the amount of $50,0000 to support the creation of DiabetesSisters’ first Educational Library.
HEIDELBERG, Germany, January 5, 2015 /PRNewswire/ -- BioMed X announced today that they have entered into a collaboration agreement with Boehringer Ingelheim to establish
Significant portion of alliance opportunity will remain unchanged; some countries will transition to exclusive promotion in 2015 INDIANAPOLIS and INGELHEIM, Germany, Oct.
LONDON and BOSTON, October 28, 2014 /PRNewswire/ -- Global top 20 pharma company streamlines R&D IT with cross-domain platform Boehringer Ingelheim,
BONN, Germany, October 14, 2014 /PRNewswire/ -- Rigontec GmbH, a privately held biopharmaceutical company developing RNA-based immunotherapeutics for the treatment of cancer
The Nation’s Premier Annual Physical Activity and Hispanic Family Health Celebration Boehringer Ingelheim Pharmaceuticals, Inc.
The Nation’s Premier Annual Physical Activity and Hispanic Family Health Celebration Dallas, TX (PRWEB) September 02, 2014 On Saturday, September 6,
All Aspects Of Litigation Surrounding The Federal Pradaxa Lawsuits Alleging Boehringer Ingelheim's Blood Thinner Caused Serious Internal Bleeding Have Been Suspended Until Completion Of A
Thousands of Pradaxa Lawsuits Currently Pending in U.S.
Boehringer Ingelheim GmbH, a German pharmaceutical company, recently announced a settlement for approximately 4,000 claims related to injuries and deaths caused by the blood thinner Pradaxa.
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.